All Type of News
Government Ensues Current and Future Efforts in Anti-Smoking Programs
The government plans to make an official announcement on December 30th detailing the revised regulation supporting the public health promotion and improvement.
The existing liability payment for public health promo...
CJ Surpasses Annual Production of IV Solutions Over 30 Million Units
CJ Pharmaceutical Division achieved its annual production of intravenous (IV) fluid sets and solutions surpassing 30 million units per year, driving the total IV solution revenue of 40 billion won for the current year...
Local Manufacturers Achieved $23 Million Worth of Contracts at CPhl Worldwide 2004The Korea Pharmaceutical Traders Association (KPTA) recently announced the successful results from participating CPhl Worldwide 2004, an international convention of pharmaceutic...
|
Medical Communities Would Not Accept Unjustified NHI Fee for MRI Test
The medical communities led by the Korea Hospital Association (KHA) are raising their concerns over the government’s current National Health Insurance (NHI) medical service fee valuation for the Magnetic Resonance Ima...
Kuhnil Signs Exclusive Marketing Rights for Senju’s Bronuck
Kuhnil Pharmaceutical recently acquired the exclusive domestic marketing rights for Bronuck (bromfenac sodium hydrate), an ophthalmic solution manufactured by Japan’s Senju Pharmaceuticals Co. Ltd.
Bronuck is a top...
Mandatory Recall System Will Become Effective Next Year
The Ministry of Health and Welfare (MOHW) announced an implementation of mandatory recall system regulation as applied to the pharmaceutical products, which will be effective during the first half of Year 2005.
The...
KFDA Posts Results of Re-Evaluation Reviews on 4,253 Antibiotic Agents
The Korea Food and Drug Administration announced the results of its re-evaluation reviews on 4,253 antibiotic agents from 9 therapeutic areas, on December 23rd.
The results of the KFDA’s re-evaluation reviews were ...
Elidel’s Claim on Its Better Efficacy over Protopic Now Challenged
In response to a recent announcement by Novartis on citing the favorable results for its Elidel (pimecrolimus) Cream 1% over Protopic (tacrolimus) Ointment 0.03%, a counter statement was recently made by the maker of ...
KFDA Denies Its Upcoming Decision to Disapprove on ‘Bacchus-S’
Amid the continuing decision delays by the Korea Food and Drug Administration (KFDA) on the possible use of a trademark ‘Bacchus-S’, a quasi-medicine, requested by Dong-A Pharmaceutical, the KFDA made an official stat...
Only 7.4% of Pharmacies Give Complete Medication Guidance
While the majority of pharmacies do provide their medication guidance at the time of dispensary, a new survey suggests that only a few pharmacies give the provision that would satisfy all the requirements as stated in...
